Containment of Mycobacterium tuberculosis (Mtb) infection requires T cell recognition of 20 infected macrophages. Mtb has evolved to tolerate, evade, and subvert host immunity. Despite a 21 vigorous and sustained CD8 + T cell response during Mtb infection, CD8 + T cells make limited 22 selection of Mtb antigens for vaccines has focused on antigens that generate immunodominant 41 responses. We propose that establishing whether vaccine-elicited, Mtb-specific T cells recognize 42
contribution to protection. Here, we ask whether the ability of Mtb-specific T cells to restrict Mtb 23 growth is related to their capacity to recognize Mtb-infected macrophages. 24
We derived CD8 + T cell lines that recognized the Mtb immunodominant epitope TB10.44-25 11 and compared them to CD4 + T cell lines that recognized Ag85b240-254 or ESAT63-17. While the 26 CD4 + T cells recognized Mtb-infected macrophages and inhibited Mtb growth in vitro, the TB10.4-27 specific CD8 + T cells neither recognized Mtb-infected macrophages nor restricted Mtb growth. 28 TB10.4-specific CD8 + T cells recognized macrophages infected with Listeria monocytogenes 29 expressing TB10.4. However, over-expression of TB10.4 in Mtb did not confer recognition by 30 TB10.4-specific CD8 + T cells. Importantly, CD8 + T cells recognized macrophages pulsed with 31 irradiated Mtb, indicating that macrophages can efficiently cross-present the TB10.4 protein and 32 raising the possibility that viable bacilli might suppress cross-presentation. Importantly, polyclonal 33 CD8 + T cells specific for Mtb antigens other than TB10.4 recognized Mtb-infected macrophages 34 in a MHC-restricted manner. 35
As TB10.4 elicits a dominant CD8 + T cell response that poorly recognizes Mtb-infected 36 macrophages, we propose that TB10.4 acts as a decoy antigen. Moreover, it appears that this 37 response overshadows subdominant CD8 + T cell response that can recognize Mtb-infected 38 macrophages. The ability of Mtb to subvert the CD8 + T cell response may explain why CD8 + T 39 cells make a disproportionately small contribution to host defense compared to CD4 + T cells. The 40 Introduction 44 Unlike most disease-causing pathogens, Mycobacterium tuberculosis (Mtb), the cause of 45 tuberculosis (TB), persists in humans because of its highly evolved ability to evade and subvert 46 the host immunity [1] . Mtb subverts vesicular trafficking, prevents phagolysosome fusion, and 47 replicates in an intracellular niche within macrophages, allowing it to evade detection by humoral 48
immunity [2] . Mtb also delays the initiation and recruitment of T cell immunity to the lung, 49 promoting the establishment of a persistent infection [3] . Despite these challenges, T cell 50 immunity does occur and plays an essential role in controlling the infection in both mice and 51 humans [3] [4] [5] . With 10 million new TB cases annually, an effective vaccine would offer a cost-52 effective way to prevent TB and attenuate this persistent global pandemic. Given the importance 53 of T cells during host defense, strategies for TB vaccines largely aim at generating memory T 54 cells rather than neutralizing antibodies. Most subunit vaccines incorporate immunodominant Mtb 55 antigens, which elicit large T cell responses [6] . Several immunodominant antigens have been 56 identified in the murine TB model, including Ag85a, Ag85b, CFP-10, . T 57 cell responses to these antigens are also frequently detectable in Mtb-infected people, and these 58 highly prevalent responses represent the basis for TB immunodiagnostic tests [8] . By 59 incorporating these immunodominant antigens into vaccines, the expectation is that antigen-60 specific T cells will contain the infection before Mtb can establish a niche and evade host immunity 61 5 CD8 + T cells to mediate protection is due to inefficient recognition of We used primary CD4 + and CD8 + T cells lines to investigate the recognition of Mtb-infected 95 macrophages by T cells specific to Ag85b, or TB10.4 . Ag85b-and ESAT-6-specific CD4 + 96 T cells recognized Mtb-infected macrophages, but under the same conditions, TB10-specific 97 CD8 + T cells did not recognize infected macrophages or inhibit bacterial growth. This was true 98 even upon examination of numerous conditions and permutations including length of infection, 99 duration of T cell and macrophage co-culture, and multiplicity of infection. TB10.4-specific CD8 + 100 T cells did recognize macrophages infected with recombinant Listeria monocytogenes expressing 101 TB10.4, but only if the bacilli could escape into the cytosol. However, overexpressing TB10.4 in 102
Mtb did not confer recognition. Importantly, macrophages pulsed with irradiated bacteria efficiently 103 cross-presented TB10.4 to CD8 + T cells, suggesting that live Mtb actively inhibited presentation. 104
Interestingly, polyclonal CD8 + T cells specific for Mtb antigens other than TB10.4 recognized infected macrophages in a MHC class I-restricted manner. Thus, while TB10.4-specific CD8 + T 106 cells do not recognize Mtb-infected macrophages, there exist other CD8 + T cells that recognize 107 subdominant antigens presented by Mtb-infected cells. Based on these data, we propose that 108 TB10.4 is a decoy antigen: it elicits a massive and persistent CD8 + T cell response, which cannot 109 recognize Mtb-infected macrophages. Such a decoy antigen may distract the CD8 + response from 110 focusing on subdominant antigens presented by infected cells, leading to evasion from host 111 immunity. 112 113 6 Results 114 TB10.4-specific CD8 + and Ag85b-specific CD4 + T cell lines sensitively recognize 115 their cognate antigens. 116 To study T cell recognition of Mtb-infected macrophages, we established antigen-specific 117 T cell lines, which unlike T cell hybridomas, facilitate the study of T cell function as well as 118 recognition. The TB10.44-11-specific CD8 + T cell line, referred hereafter as TB10Rg3, has a distinct 119 TCR cloned originally from TB10.44-11-tetramer + CD8 + T cells isolated from infected mice and 120 expressed in retrogenic mice [19] . The Ag85b240-254-specific CD4 + T cell line, referred hereafter as 121 P25 cells, was derived from P25 TCR transgenic mice [24] . To confirm their antigen-specificity, 122
we co-cultured the P25 or TB10Rg3 T cells with thioglycolate-elicited peritoneal macrophages 123 (TGPMs) pulsed with or without their cognate peptides and then measured their expression of 124 CD69 and Nur77. While both CD69 and Nur77 are T cell activation markers, increases in Nur77 125 expression indicate TCR-mediated activation more specifically [25, 26] . After co-culture with 126
TGPMs pulsed with Ag85b241-256 peptide, Nur77 expression by P25 cells peaked after 2 hours 127 (Fig 1a, b) , while CD69 expression continued to increase (Fig 1c, d ). TB10Rg3 T cells exhibited 128 similar Nur77 and CD69 expression patterns after their co-culture with TGPMs pulsed with the 129 TB10.44-11 peptide (IMYNYPAM) but not with a control peptide (IMANAPAM) (Fig 1e-h ). Since the 130 increase in Nur77 expression was transient, we next tested whether CD69 and IFNγ could be 131 7 Ag85b-specific CD4 + T cells, but not TB10.4-specific CD8 + T cells, restrict 139 intracellular bacterial replication.
140
Given that a primary function of T cells during Mtb infection is to restrict bacterial growth, 141 we determined whether these T cell lines could limit intracellular mycobacterial growth in vitro. 142
We infected TGPMs with H37Rv, a virulent Mtb strain that expresses both TB10.4 and Ag85b in 143 vitro [21, 27] . To assess whether any bacterial growth inhibition observed was dependent on 144 cognate recognition, we infected both MHC-matched (i.e., H-2 b ) and mismatched (i.e., H-2 k ) 145 macrophages. T cells were added on day 1 post-infection, and the number of colony forming units 146 (CFU) was assayed 96 hours later. In the absence of T cells, Mtb grew significantly (p<0.01) ( Fig  147   2 ). P25 T cells significantly inhibited intracellular bacterial growth in H37Rv-infected TGPMs 148 (p<0.0001). Addition of Ag85b peptide to the infected macrophages did not further enhance the 149 ability of P25 T cells to inhibit bacterial growth, suggesting that their activation was maximal. As 150 expected, P25 T cells only inhibited bacterial growth in MHC-matched macrophages, indicating 151 that growth inhibition mediated by T cells required cognate recognition under these conditions. 152
In contrast, TB10Rg3 T cells did not inhibit bacterial growth (Fig 2) . We considered 153 whether the inability of TB10Rg3 to inhibit bacterial growth was due to a lack of recognition of the 154 infected macrophages or a defect in the T cells' effector functions. When Mtb-infected TGPMs 155 were pulsed with the TB10.44-11 peptide for one hour prior to adding the T cells, TB10Rg3 T cells 156 significantly reduced bacterial growth (p<0.0001) (Fig 2a) . Thus, under the same conditions where 157 P25 T cells significantly suppressed intracellular Mtb growth in a MHC-restricted manner, 158
TB10Rg3 T cells failed to inhibit bacterial growth. 159
We next considered whether the inability of TB10Rg3 to restrict intracellular bacterial 160 growth was true for other TB10.44-11-specific CD8 + T cells. To obtain TCRs representative of other 161 clonally expanded TB10.44-11-specific CD8 + T cells, TB10.44-11-tetramer + CD8 + T cells from Mtb-162 infected C57BL/6 mice were single cell sorted, and both the TCR CDR3α and CDR3β regions 163 8 were sequenced ( Fig S2) . Three TCRs representative of clonally expanded T cells (TB10RgL,  164 TB10RgR, and TB10RgQ) were cloned ( Fig S2) . In addition, a fourth TCR (TB10RgP), not 165 previously identified by NexGen sequencing, was also cloned. All these TCRs responded 166 specifically to the TB10.44-11 epitope and expressed TCRs distinct from TB10Rg3 ( Fig S3) . We 167 generated T cell lines from these retrogenic mice, as described for TB10Rg3. TB10RgP, 168
TB10RgL, and TB10RgR did not inhibit bacterial growth (Fig 2b) . However, if the Mtb-infected 169 macrophages were pulsed with the TB10.44-11 peptide before T cell addition, then TB10RgP, 170
TB10RgL, and TB10RgR T cells all inhibited bacterial growth significantly (Fig 2b) . Since TB10.44-171 11-specific CD8 + T cells only inhibited bacterial growth when their cognate peptide was added to 172
Mtb-infected macrophages, we conclude that, although they express the effector function required 173 to restrict intracellular bacterial growth, these TB10.44-11-specific CD8 + T cells do not recognize 174
Mtb-infected macrophages. 175 176 177 Ag85b-specific CD4 + T cells, but not TB10.4-specific CD8 + T cells, recognize Mtb-178 infected macrophages.
179
To further investigate TB10Rg3 and P25 T cells recognition of Mtb-infected cells, we next 180 investigated the kinetics of Mtb antigen presentation. After Mtb infection, TGPMs were cultured 181 for various lengths of time before adding the T cells. To assay antigen presentation, we added 182 the T cells for two hours and then measured Nur77 and CD69 (see Fig 1 for kinetics) . When 183 added immediately after infection (i.e., day 0), P25 T cells recognized Mtb-infected macrophages 184 based on the induction of Nur77 and CD69 (Fig 3a, b ). Under these conditions, there was no 185 increase in Nur77 or CD69 expression by TB10Rg3 T cells (Fig 3c, d ). We next chose later time 186 points, which might allow Mtb to adapt to the intracellular environment and potentially let the 187 TB10.4 antigen accumulate. TB10Rg3 T cells were added to infected macrophages on days 1, 3, 188 9 or 5 post-infection. Again, we did not observe any increase in Nur77 or CD69 expression (Fig 3e,  189 f). As a control for T cell health and function, we co-cultured TB10. 44-11-peptide-pulsed-, 190 uninfected-macrophages with the TB10Rg3 T cells and observed significant increases in their 191
Nur77 and CD69 expression ( Fig 3) . 192
Despite assessing recognition on multiple days, we considered whether the short assay 193 period (i.e. 2 hours) might not detect recognition of Mtb-infected macrophages by TB10Rg3 T 194 cells, especially if presentation of TB10.4 is inefficient or asynchronous. Therefore, we used IFNγ 195 production as a cumulative indicator of T cell activation during a 72-hour co-culture experiment. 196
Since cytokine-driven activation (e.g., IL-12, IL-18) can stimulate IFNγ production by T cells 197 independently of TCR signaling, we used MHC-matched (H-2 b ) or mismatched (H-2 k ) TGPM to 198 assess cognate recognition [26, [28] [29] [30] . As the infectious dose (MOI, multiplicity of infection) 199 increased, P25 T cells produced more IFNγ when co-cultured with MHC-matched, but not MHC-200 mismatched, Mtb-infected TGPMs (Fig 3g) . In contrast, TB10Rg3 T cells did not produce IFNγ 201 when co-cultured with Mtb-infected TGPMs (Fig 3h) . As before, TB10Rg3 T cells produced IFNγ 202 when co-cultured with uninfected macrophages pulsed with the TB10.44-11 peptide (Fig 3h) . 203
We next used the TB10.44-11-specific CD8 + T cell lines TB10RgP, TB10RgL and TB10RgR 204 to address whether TB10.44-11-specific CD8 + T cells other than TB10Rg3 can recognize Mtb-205 infected macrophages. While the TB10RgP, TB10RgL, and TB10RgR CD8 + T cell lines produced 206
IFNγ when cultured with uninfected macrophages pulsed with the TB10.44-11 peptide, none 207 produced IFNγ following a 72-hour co-culture with Mtb-infected macrophages (Fig 3i) . These data 208
show that, regardless of the time point of T cell addition or the length of co-culture, P25 T cells, 209 but not TB10.44-11-specific CD8 + T cells, recognized Mtb-infected macrophages, based on their 210 increased Nur77 and CD69 expression as well as their IFNγ production. 211 212
TB10.4-specific CD8 + T cells do not recognize lung cells from Mtb-infected mice.

213
During in vivo infection, Mtb infects a variety of myeloid cells, and this diversity changes 214 10 over the course of the infection [31] [32] [33] . We considered that lung myeloid cells from Mtb-infected 215 mice are more physiologically relevant than TGPMs. Thus, we isolated MHC class II + lung cells 216 from Erdman-infected, RAG-1-deficient mice 4 weeks post-infection and tested their ability to 217 present Mtb antigens to TB10Rg3 T cells. We used RAG-1-deficient mice because of the 218 possibility that CD8 + T cells in the lungs of Mtb-infected, wild type mice may recognize and 219 eliminate any lung cells presenting the TB10.4 antigen. Since Mtb downregulates Ag85b 220 expression by 3 weeks post infection [11, 12] , we used an ESAT-6-specific CD4 + T cell line 221 derived from C7 transgenic mice, which we refer to as C7 T cells [10, 34] . The immunodominant 222 antigen ESAT-6 retains high levels of expression throughout infection and elicits a dominant CD4 + 223 T cell response in C57BL/6 mice [11] . Due to the difficulty in obtaining large numbers of MHC 224 class II + cells from uninfected, RAG-1-deficient mice, we used TGPMs from age-matched, RAG-225 1-deficient mice as a source of uninfected, inflammatory macrophages. We stained C7 or 226 TB10Rg3 T cells with 5uM of the proliferation dye eFluor450 (eBioscience) before co-culturing 227 them with the lung myeloid cells. After 72 hours, we measured the T cell proliferation as a marker 228 of T cell recognition. C7 T cells proliferated extensively when co-cultured with the infected lung 229 myeloid cells but not when co-cultured with uninfected TGPMs (Fig 4a, b) . In contrast, TB10Rg3 230 T cells did not proliferate when co-cultured with the lung myeloid cells (Fig 4c, d) . To assess 231 whether TB10Rg3 T cells could proliferate if TB10.4 was present, we pulsed the lung APCs with 232 the TB10.44-11 peptide for 1 hour before adding the TB10Rg3 T cells. As predicted, TB10Rg3 T 233 cells proliferated after 72 hours of co-culture with peptide-pulsed, lung myeloid cells (Fig 4c, d) . 234
We considered the possibility that Mtb in lung myeloid cells may not grow well in vitro, 235 leading to altered antigen abundance that could affect T cell recognition. To address this 236 possibility, we measured the bacterial burden in the lung myeloid cells. There was a 3-fold 237 increase in the bacterial numbers between the beginning (d1) and the end (d4) of the experiment, 238
indicating that the bacteria remained viable (Fig 4e) . Together, these data indicate that, under the 239 conditions in which C7 T cells recognized lung myeloid cells from Mtb-infected mice, TB10Rg3 T 240 11 cells did not recognize these lung myeloid cells. 241 242 TB10Rg3 CD8 + and P25 CD4 + T cells recognize macrophages infected with TB10.4-243 or Ag85b-expressing Listeria. 244 We next investigated whether the location of the antigen might affect the presentation of 245 TB10.4 since the MHC class I antigen presentation pathway primarily samples the cytosol, 246
whereas Mtb is a classic phagosomal pathogen. TB10.4-specific CD8 + T cells are primed and 247 expanded during Mtb infection, so the TB10.4 antigens must be cross-presented; however, 248 whether Mtb-infected macrophages can competently cross-present mycobacterial antigens is 249 unknown. We investigated these possibilities using DLLO or DActA mutant strains of Listeria 250 monocytogenes engineered to express the full length TB10.4 protein, hereafter referred to as 251 DLLO.TB10.4 or DActA.TB10.4, respectively. Both are attenuated strains: the DLLO.TB10.4 252 mutant cannot escape from the vacuole, while the DActA.TB10.4 mutant can escape from the 253 vacuole but not from the cell. Hence, the TB10.4 protein made by the DLLO.TB10.4 strain will 254 remain trapped in the phagosome, but the TB10.4 protein made by the DActA.TB10.4 strain will 255 gain access to the cytosol. 256
TB10Rg3 T cells recognized DActA.TB10.4-infected TGPMs based on an increased 257 frequency of Nur77-expressing cells (p<0.005) and the Nur77 MFI of all TB10Rg3 T cells 258 (p<0.005) (Fig 5a-c) . Bafilomycin, which inhibits vacuolar acidification and impairs the entry of the 259
DActA.TB10.4 strain into the cytosol, diminished the frequency of Nur77-expressing cells 260 (p<0.005) and Nur77 MFI (p<0.01) (Fig 5a, top, b, c) . In contrast, TB10Rg3 T cells co-cultured 261 with DLLO.TB10.4-infected TGPMs showed no increase in the frequency of Nur77-expressing 262 cells or the Nur77 MFI (Fig 5a bottom, d, e ). If recombinant listeriolysin (rLLO), the protein missing 263 from the DLLO.TB10.4 strain, was added to the infected macrophages, an increase in the 264 frequency of Nur77-expressing TB10Rg3 T cells (p<0.01) and the Nur77 MFI (p<0.01) became 12 apparent. We also determined whether P25 T cells recognized Ag85b-expressing Listeria 266 monocytogenes using the recombinant Listeria strains DActA.Ag85b and DLLO.Ag85b. Based on 267 the propensity of MHC class II to present extracellular and vacuolar antigens, P25 cells 268 recognized TGPMs infected with either DActA.Ag85b or DLLO.Ag85b, based on an increase in 269 the frequency of Nur77-expressing T cells and Nur77 MFI (p<0.005) (Fig 5g, h) . These results 270
show that 1) TGPMs can efficiently process the full length TB10.4 protein and present the 271 TB10.44-11 epitope via MHC class I; 2) this process is more efficient when the bacteria are in the 272 cytosol; and 3) TB10Rg3 T cells can efficiently recognize TB10.44-11 presented during a live 273 infection. 274 275 TB10.4-specific CD8 + T cells do not recognize Mtb overexpressing TB10.4. 276 We considered several additional possibilities as to why the TB10Rg3 T cells did not 277 recognize Mtb-infected macrophages. Antigen abundance can affect T cell recognition, so we 278 next tested whether increasing the level of TB10.4 protein expression might enhance TB10Rg3 T 279 cell recognition of Mtb-infected macrophages. Since Mtb secretes esxH (TB10.4) together with 280 esxG as a heterodimer [35] , we developed a recombinant strain of H37Rv (esxGH-OE.Mtb), which 281 overexpresses both esxG and esxH under the control of a tet ON promoter. After tetracycline 282 induction for 24 hours, the esxG and esxH mRNA expression increased multiple folds (Fig 6a) . 283
Prior to in vitro infection, we treated esxGH-OE.Mtb with or without tetracycline. The next day, 284
TGPMs were infected with induced or uninduced esxGH-OE.Mtb. P25 T cells produced similar 285 amounts of IFNγ when co-cultured with macrophages infected with either uninduced or induced 286 esxGH-OE.Mtb, which was expected since Ag85b expression should not be altered (Fig 6b) . 287
Despite increasing the production of TB10.4 by Mtb, TB10Rg3 T cells still did not recognize Mtb-288 infected macrophages (Fig 6c) . Although we cannot be certain that the induction of EsxGH leads 289 to an increased amount of antigen delivered to the antigen processing pathway, this result 290 13 suggests that antigen abundance is not limiting TB10.4-specific CD8 + T cell recognition of Mtb-291 infected macrophages. 292 293 Mtb infection does not significantly impair MHC class I and II expression by 294 macrophages. 295 We also investigated whether Mtb may inhibit MHC class I expression by infected TGPMs. 296
Mtb and TLR2 agonists inhibit IFNγ-induced MHC class II expression by bone marrow derived 297 macrophages, and the mycobacterial PPE38 protein can inhibit MHC class I expression in 298 RAW264.7 macrophages and TGPMs infected with Mycobacterium smegmatis [36, 37] . 299 Therefore, we asked whether Mtb impaired MHC class I expression in our in vitro infection system, 300 especially since the TGPMs were not pre-activated with IFNγ prior to infection. We measured 301 TGPMs did not achieve the same peak levels (Fig 6d, e; dotted lines). As expected, the regulation 306 of MHC class II was more sensitive to IFNγ. Uninfected TGPMs expressed low baseline levels of 307 MHC class II (Fig 6f, g ; solid lines). IFNγ pretreatment resulted in a >100-fold increase in MHC 308 class II median fluorescence intensity (MFI) in the uninfected TGPMs, which peaked on day 3 309 with a >2000-fold increase over the baseline (Fig 6f, g; dotted lines). Mtb-infection alone did not 310 significantly affect MHC class II expression, and consistent with previous studies, Mtb significantly 311 impaired the induction of MHC class II by IFNγ pretreatment (Fig 6f, g) . These data show that, in 312 our in vitro infection model where the TGPMs were unstimulated, Mtb infection did not inhibit class 313 I and II MHC expression. Importantly, the differences in MHC class I or class II expression by 314
Mtb-infected macrophages cannot explain why P25 T cells, but not TB10Rg3 T cells, recognized 315 14 infected macrophages. 316 317
Macrophages cross-present antigens from non-viable Mtb to TB10.4-specific CD8 +
318
T cells. 319 Next, we hypothesized that Mtb may interfere with MHC class I presentation of 320 mycobacterial antigens. Therefore, we tested the ability of the P25 and TB10Rg3 T cell lines to 321 recognize TGPMs cultured with γ-irradiated, nonviable Mtb. Activation of pattern recognition 322 receptors such as TLR2 and TLR4 by large amounts of dead bacteria might induce large amounts 323 of IL-12 and IL-18, resulting in cytokine-driven T cell activation. Taking this concern into 324 consideration, we used MHC-mismatched TGPMs as a control. We pulsed macrophages with a 325 dose titration of γ-irradiated Mtb, then added TB10Rg3 or P25 T cells, and measured IFNγ 326 secretion by the T cells after 72 hours. Both P25 and TB10Rg3 T cells produced high amounts of 327
IFNγ when cultured with MHC-matched (i.e., H-2 b ) but not with MHC-mismatched (i.e., H-2 k ) 328 TGPMs, and this response was dose dependent (Fig 6h, 
334
Along with the previous finding that TB10.44-11-specific CD8 + T cells make up ~40% of total 335 lung CD8 + T cells during infection (S1 Figure) [19], our finding that TB10Rg3 T cells do not 336 recognize Mtb-infected macrophages suggests that TB10.4 may be a decoy antigen. This raises 337 the question whether the inability to recognize Mtb-infected macrophages is a general feature of 338 the CD8 + T cell response to Mtb, or if this is a unique feature of TB10.4-specific CD8 + T cells. 339 Therefore, we determined whether polyclonal CD8 + T cells from the lungs of infected mice could 340 15 recognize Mtb-infected macrophages. We carried out aerosol infection of C57BL/6 mice with 341 Erdman, and, 6-8 weeks post infection, we purified polyclonal CD4 + or CD8 + T cells from their 342 lungs and co-cultured them with Mtb-infected macrophages. After 72 hours of co-culture, 343 polyclonal CD4 + T cells produced high amounts of IFNγ in a MHC-restricted manner (Fig 7a) . 344
Interestingly, polyclonal CD8 + T cells also produced IFNγ in a MHC-restricted manner when co-345 cultured with Mtb-infected macrophages (Fig 7b) . These results indicate that other antigen-346 specific CD8 + T cells recognizing Mtb-infected macrophages do exist, and infected TGPMs can 347 present Mtb antigens to CD8 + T cells. However, based on the high abundance of TB10.4-specific 348 CD8 + T cells post infection (S1 Figure) , the non-TB10.4-specific, Mtb-specific CD8 + T cells may 349 be dwarfed by the dominant TB10.4-specific CD8 + T cells. 350
To better assess whether the IFNγ production by polyclonal CD8 + T cells arose 351 predominantly from non-TB10.4-specific CD8 + T cells, we used the TB10.44-11-tetramer to 352 separate TB10.4-specific and non-TB10.4-specific, polyclonal CD8 + T cells from the lungs of 353 infected mice. After 72-hour co-culture with Mtb-infected macrophages, TB10.44-11-tetramer 354 negative CD8 + (non-TB10.4-specific CD8 + ) T cells produced significantly higher IFNγ compared 355 to that of uninfected control (p<0.005), and the production was MHC class I restricted (Fig 7c) . In 356 contrast, TB10. 44-11-specific CD8 + T cells produced IFNγ in a non-MHC-restricted manner during 357 co-culture with both uninfected and Mtb-infected macrophages (Fig 7d) . We cannot exclude the 358 possibility that the tetramer isolation might have inadvertently activated the TB10.44-11-specific 359 CD8 + T cells. Nevertheless, these data show that polyclonal, TB10.44-11-tetramer negative CD8 + 360 T cells recognized Mtb-infected macrophages, supporting the notion of a subdominant T cell 361 response that may be effective at detecting Mtb. 362 16 Discussion 363 A complexity in defining T cell recognition is distinguishing cognate from non-cognate 364 recognition. T cell IFNγ production, a common readout for recognition, can be stimulated by IL-365 12 and IL-18, two cytokines secreted by Mtb-infected cells [26, [28] [29] [30] . Even cognate recognition 366 does not always signify recognition of infected cells. Uninfected macrophages and dendritic cells 367 (DCs) can acquire exosomes, soluble proteins, apoptotic vesicles or necrotic debris containing 368 non-viable bacilli or its antigens, and present these to T cells [13, [38] [39] [40] . This detour pathway 369 allows T cells to be activated by uninfected DCs [38, 41] . Thus, T cell recognition of infected 370 macrophages, which is central to our fundamental paradigm of TB pathogenesis, remains poorly 371 defined. 372
Our study advances the understanding of T cell recognition of Mtb-infected cells. By 373 focusing on TCR-mediated recognition, our data show that T cells specific to immunodominant 374 antigens vary in their ability to recognize Mtb-infected macrophages. Despite being a persistent 375 and dominant population of CD8 + T cells in the lungs of Mtb-infected mice, TB10.44-11-specific 376 CD8 + T cells do not recognize Mtb-infected macrophages. While we primarily used TGPMs, which 377
have been used to model human macrophages [42, 43] , we also showed that TB10.4-specific 378 CD8 + T cells failed to recognize lung APCs from infected mice. Importantly, concurrent with our 379 analysis of CD8 + T cells, we systematically assessed recognition of Mtb-infected macrophages 380 by Ag85b-specific (i.e., P25) and ESAT-6-specific (i.e., C7) CD4 + T cells. Both recognized Mtb-381 infected macrophages and inhibited bacterial growth (here and [10]). Thus, under conditions that 382 activated Mtb-specific CD4 + T cells, no activation of TB10.4-specific CD8 + T cells occurred. This 383 finding has many implications, among which the most important is that not all Mtb-specific T cells 384 recognize Mtb-infected macrophages. 385
These results led us to re-examine the evidence that CD8 + T cells recognize infected cells. 386
In our evaluation of the literature, among the best evidence is: (1) cognate recognition, and the frequencies were lower than expected. The human studies only used 391 DC and not macrophages and used a high MOI, raising concerns about death of infected cells 392 and presentation of nonviable antigen. Nevertheless, these studies support the idea that CD8 + T 393 cells recognize infected cells, but their frequency that recognize infected macrophages might be 394 lower than we previously expected. Such a finding might explain why CD8 + T cells make a 395 disproportionately small contribution to host defense, even though Mtb infection elicits a robust 396 CD8 + T cell response. 397
We investigated several mechanisms that might explain why TB10.4-specific CD8 + T cells 398 do not recognize infected macrophages. One possibility is the access of the TB10.4 antigen to 399 the MHC class I processing pathway. Mtb can disrupt the phagosomal membrane and translocate 400 into the cytosol [54], though this action often occurs later in infection and leads to necrosis of the 401 macrophage [55] . We saw no evidence of recognition even at late time points such as days 4-5 402 post infection (Fig 3) , when phagosomal disruption and bacterial translocation occurs [55] . The 403 importance of antigen location became apparent during the Listeria infection experiments, where 404 infected macrophages presented TB10.44-11 only when the bacteria could enter the cytosol (i.e., 405
DActA.TB10 but not DLLO.TB10). The Listeria experiments also provided an additional insight. 406
Lindenstrom et al report that vaccination with TB10.4 (EsxH), which has a leucine at position 12 407 (i.e., IMYNYPAML), inefficiently generates TB10.4-specific CD8 + T cells [56] . However, 408 vaccination with TB10.3 (EsxR), a related antigen that also contains the same epitope followed 409 by a methionine (i.e., IMYNYPAMM), elicits TB10.4-specific CD8 + T cells. Based on that finding, 410 they conclude there is a processing defect that prevents the generation of the TB10.44-11 epitope 411 from the TB10.4 protein. However, they also find that TB10.4-specific CD8 + T cells elicited by 412 TB10.3 vaccination recognize splenocytes pulsed with the rTB10.4 proteins, showing that the full 413 18 length TB10.4 protein can be processed and presented. These data indicate that the lack of 414 vaccine-elicited TB10.4-specific CD8 + T cells is due to a problem with priming after vaccination 415 instead of an inability to process the IMYNYPAM epitope. Moreover, our data using TB10.4-416 expressing Listeria show that TGPMs can process the full length TB10.4 protein and present the 417 TB10.44-11 epitope. Therefore, we conclude that amino acid sequence of TB10.4 does not hinder 418 its processing. The Listeria experiments also show the potential importance of antigen location 419 and raise the possibility that sequestration of the TB10.4 antigen in the phagosome renders it 420 inaccessible to the MHC class I presentation pathway. 421
Low antigen abundance could also explain the lack of recognition. We have previously 422 argued that there is limited amount of TB10.4 antigen presentation in the lungs of infected mice, 423 leading to extreme bias in the TCR repertoire of the TB10.4-specific CD8 + T cell response and 424 defects in the memory-recall response in vivo [19, 23] . To test the possibility of low antigen 425 abundance, we overexpressed EsxG and EsxH (TB10.4) together but did not see greater T cell 426 recognition of Mtb-infected macrophages, suggesting that abundance might not be the issue. 427
Unexpectedly, macrophages pulsed with γ-irradiated Mtb were recognized by TB10.4-428 specific CD8 + T cells, raising the possibility that live Mtb actively inhibits MHC class I presentation 429 of TB10.4. This is particularly interesting since the presentation of CFP10, another ESAT-6-like 430 protein, by human DCs to CD8 + T cells requires viable Mtb; DCs given heat-killed bacteria do not 431 present CFP10 to T cells [53] . While these data suggest that presentation requires active 432 secretion of CFP10 [57, 58] , the heat-killing process could have destroyed CFP10, or there might 433 not have been sufficient amounts of CFP10 available in the non-viable bacteria. In combination 434 with our data showing polyclonal CD8 + T cells recognize Mtb infected macrophages, these data 435
show that it is possible that certain antigens are presented by live Mtb while others are actively 436 prevented from being sampled by MHC class I. 437
Ag85b is an immunodominant antigen with an epitope recognized by CD4 + T cells in 438 C57BL/6 mice. In vivo data shows that Ag85b-specific CD4 + T cells can recognize Mtb-infected 439 19 cells early during infection; however, recognition decreases after infection is established [12, 14, 440 15, 59, 60] . The inability of Ag85b-specific CD4 + T cells to efficiently recognize Mtb-infected bone-441 marrow derived macrophages (BMDMs) or bone-marrow derived dendritic cells (BMDCs) stems 442 from a combination of reduced Ag85b expression by Mtb and because infected cells actively 443 export Ag85b into the extracellular milieu [12, 13] . In our experiments, we found that P25 T cells 444 recognized Mtb-infected macrophages and inhibited bacterial growth in a MHC-restricted manner. 445
A difference between the studies is the duration of macrophage and T cell co-culture. Grace et al 446 examined 16-24 hours and found a lack of recognition, whereas our assays focused on 72-96 447 hours and detected recognition. Moreover, it is unknown whether Mtb-infected cells still exported 448 antigens after the initial 24 hours of infection. Furthermore, the exported Ag85b could be taken 449 up by infected cells during longer co-cultures, leading to their recognition by T cells. Finally, it is 450 possible that cognate recognition of uninfected cells that present Ag85b could activate CD4 + T 451 cells in a TCR-mediated manner, inducing IFNγ and indirectly controlling Mtb replication in 452 macrophages. Nonetheless, under conditions that activate Mtb-specific CD4 + T cells, we could 453 not observe activation of TB10.4-specific CD8 + T cells. 454
The TB10.44-11 epitope has been extensively used to characterize CD8 + T cell responses 455 in the mouse model of TB, and TB10.4-specific CD8 + T cell responses have also been 456 characterized in people with tuberculosis [19, 21, 23, 56, [61] [62] [63] . The finding that TB10.4-specific 457 CD8 + T cells do not recognize infected macrophages was unexpected, particularly since TB10.4-458 specific CD8 + T cells persist in the lungs of infected mice and become more dominant with time 459 [18, 19] . From these experiments, two questions warrant further investigation: 1) whether the 460 CD8 + T cells specific to other epitopes of TB10.4 also inefficiently recognize infected 461 macrophages, and 2) whether the species or the host genetic background influence recognition 462 of infected cells. 463
In retrospect, our findings may partially explain why eliciting TB10.4-specific CD8 + T cells 464 by vaccination fails to protect mice against Mtb infection [23, 56] . While vaccination with 465 20 immunodominant antigens recognized by CD4 + T cells (e.g., Ag85b, ESAT-6) induce moderate 466 protection [64, 65] , we must consider the possibility that these antigens may not be the best 467 stimulators of protective immunity. Ag85b-specific CD4 + T cells have variable efficacy, in large 468 part due to its reduced expression by the bacterium as early as 3 weeks after infection [11, 12] . 469 However, by their nature, the recruitment of memory T cell responses specific for 470 immunodominant antigens is only incrementally faster than the primary T cell response [10, 23] . 471
Thus, a crucial question for vaccine development is whether other Mtb antigens resemble TB10.4, 472 in that they elicit T cell responses that fail to recognize infected macrophages. We did detect 473 polyclonal CD8 + T cells that recognized Mtb infected macrophages, corroborating a previous 474 study showing that polyclonal CD8 + T cells from infected mice can lyse Mtb-infected cells [48] . 475
These data indicate that there are antigens presented by Mtb-infected cells, even if those antigens 476 may be subdominant compared to TB10.4. Thus, future vaccine developments will benefit by 477 identifying antigen targets based on their ability of being presented rather than only their 478 immunogenicity. 479
Priming of TB10.4-specific CD8 + T cells occurs early after Mtb infection in the lung draining 480 lymph node (LN) [23, 66] . Yet it is unknown whether priming of naïve T cells occurs via Mtb-481 infected DCs, or uninfected DCs that acquire antigen through uptake of apoptotic blebs containing 482
Mtb proteins [38, 41] , or by the transfer of antigen from cell to cell [40] . Priming by an uninfected 483 cell can have detrimental consequences if the infected cell presents a different repertoire of Mtb 484 antigens. Considering our findings, we propose that TB10.4 is a decoy antigen: TB10.4-specific 485 CD8 + T cells expand in the LN during priming, accumulate in the lungs, but ineffectively recognize 486
Mtb-infected macrophages. This raises the hypothesis that not all immune responses elicited by 487
Mtb provide benefits to the host. Interestingly, Mtb genes encoding epitopes recognized by T cells 488 are more highly conserved than other DNA elements, implying that T cell recognition of these Mtb 489 epitopes may provide a survival advantage to the bacterium [67, 68] . For example, T cell 490 dependent inflammation may benefit Mtb by promoting transmission. Even though TB10.4 is more 491 21 variable than most other antigens, our results support these genetic data [67, 68] . Thus, Mtb 492 focuses the CD8 + T cell response on the decoy antigen TB10.4 and distracts the immune 493 response from other antigens that might be targets of protective immunity, successfully evading 494 T cell immunity and enabling it to establish itself as persistent infection. 495 
Materials and Methods
Generation of CD8 + and CD4 + T cell lines 520
Retrogenic mice expressing TB10Rg3 TCR specific for the TB10.44-11 epitope were 521 generated as previously described [19] . The TB10Rg3 CD8 + T cells were isolated from these 522 mice, stimulated in vitro with irradiated splenocytes pulsed with the peptide TB10.44-11 in complete 523 media containing IL-2. P25 or C7 CD4 + T cells were isolated from transgenic P25 or C7 mice, 524 respectively [24, 34] . The P25 and C7 cells were stimulated in vitro with irradiated splenocytes 525 pulsed with the Ag85b241-256 peptide or the ESAT-61-15, respectively, in complete media containing 526 IL-2 and anti-IL-4. After the initial stimulation, these T cells were split every two days for 3-4 527 divisions and rested for two to three weeks. After the initial stimulation, the cells were cultured in 528 complete media containing IL-2 and Peptides 530
The following synthetic peptide epitopes were used as antigens: TB10.44-11 531 (IMYNYPAM); Ag85b241-256 (QDAYNAAGGHNAVFN); and ESAT-61-15 (MTEQQWNFAGIEAAA). 532
We also generated a negative control peptide predicted to not bind to H-2 K b : IMANAPAM. The 533 peptides were obtained from New England Peptides (Gardner, MA). 534
As positive controls assessing the function of macrophages to present antigen, uninfected 535 macrophages and, in certain experiments, infected macrophages were pulsed with the peptides 536 of interest. We pulsed macrophages by incubating 10uM of the peptides of interest with the 537 macrophages in supplemented complete RPMI 1640 media for 1 hour. After incubation, the cells 538 were washed 3 to 5 times with fresh supplemented complete RPMI 1640 media. The cells were 539 then resuspended in supplemented complete RPMI 1640 media for experiments. 540
In vitro Mtb infection 541
H37Rv was grown as previously described [28] . Bacteria was grown to an OD600 of 0.6 -542 1.0, washed in RPMI, opsonized with TB coat (RPMI 1640, 1% heat-inactivated FBS, 2% human 543 serum, 0.05% Tween-80), washed again and filtered through a 5 micron filter to remove bacterial 544 clumps. The bacteria were counted using a Petroff-Hausser chamber. Infection was performed 545 as previously described [28] . The final multiplicity of infection (MOI), based on plating CFU, was 546 24 0.2-0.8 for all experiments. For CFU-based, bacterial growth inhibition assays, T cells were added 547 at a ratio of 5 T cells to each macrophage. Four replicate wells were used for each condition. Cell 548 cultures were lysed by adding 1/10 th volume of with 10% Triton X-100 in PBS (final concentration 549 of 1%), and CFUs were determined by plating in serial dilutions of the lysates on Middlebrook 550 7H10 plates. CFUs were enumerated after culture for 21 days at 37°C and 5% CO2. 551 
In vivo aerosol Mtb infection and lung cell isolation
Listeria infections 580
The recombinant Listeria strains have been previously described [23] . For in vitro 581 infections, they were grown to an OD600 of 0.6-1.0 in BHI media (Sigma Aldrich) with 10 ug/ml 582 chloramphenicol (Sigma Aldrich) at 30°C. Macrophages were infected with the Listeria strains 583 using a MOI 50, for 45 minutes. Extracellular bacteria were eliminated by adding 60 ug/ml 584 gentamicin (Sigma Aldrich) for 20 minutes. Bacterial burden was assessed by lysing the infected 585 macrophages with 1% TritonX-100 in PBS, and plating serial dilutions of the lysate on BHI 586 agarose supplemented with 10ug/ml chloramphenicol (Sigma Aldrich, St. Louis, MO). 587
Recombinant listeriolysin (Prospec, East Brunswick, NJ) was added in some experiments at 2 588 ug/ml for 30 minutes, and any excess was washed away. Bafilomycin (InvivoGen, San Diego, CA) 589 was added in some experiments at 5 uM for 30 minute, before being washed away. 590
Generation of TB10.4-overexpressing Mtb strains
591 pJR1103 was cleaved with EcoRI-HF and SalI-HF [70] . mCherry preceded by the groEL2 592 promoter from H37Rv was inserted by HiFi Assembly. The resulting plasmid was cleaved with 593 NdeI and NotI-HF. The esxGH gene from H37Rv, along with 12 upstream nucleotides, was 594 inserted by HiFi Assembly following the plasmid-borne tetracycline-inducible promoter. All 595 enzymes used above were purchased from New England Biolabs. The resulting plasmid (pGB6) 596 was electroporated into Mtb H37Rv and integrated at the L5 site. RNA was purified from induced 597 26 and uninduced cultures using TRIzol (ThermoFisher) and chloroform extraction, followed by 598 purification on Zymo columns. cDNA was produced with Superscript IV (ThermoFisher), and 599 quantitative PCR was performed using the iTaq SYBR Green Supermix (Bio-Rad, Hercules, CA) 600 on an Applied Biosystems Viia 7 thermocycler. 601
Irradiated H37Rv
602
The following reagent was obtained through BEI Resources, NIAID, NIH: Mycobacterium 603 tuberculosis, Strain H37Rv, Gamma-Irradiated Whole Cells, NR-14819. The irradiated H37Rv 604 was gently sonicated using a cup-horn sonicator at a low power to disperse bacterial clumps while 605 limiting bacterial lysis. The number of bacteria were approximated by measuring the turbidity at 606 OD600, and correlating it with live H37Rv (OD600 = 1 is equivalent to 3.0x10 8 CFU/ml). To pulse 607
TGPMs, diluted, sonicated, γ-irradiated H37Rv were added to adherent macrophages for one 608 hour before repeatedly washing the cultures to remove residual extracellular bacteria. 609
Subsequently, TB10Rg3 or P25 T cells were added at a ratio of 1 T cell to 1 macrophages. After 610 72 hours, the amount of IFNγ in the supernatants was measured using Mouse IFNγ ELISA MAX 611 kits (Biolegend, San Diego, CA). 612
Flow Cytometry Analysis
613
The following cell surface antigens were detected by flow cytometry using the following 614 antibodies: mouse CD4 (clone GK1.5), CD8 (clone 53-6.7), CD3ε (clone 145-2C11), CD69 (clone 615 H1.2F3), I-A/I-E (clone M5/114.15.2), and H-2K b (clone AF6-88.5) (all from Biolegend). BV421-616 and APC-conjugated, TB10.44-11-loaded, H-2K b tetramers were obtained from the National 617
Institutes of Health Tetramer Core Facility (Emory University Vaccine Center, Atlanta, GA). 618
Zombie Violet Fixable viability dye (Biolegend) or the Live/Dead Fixable Far Red Dead Cell stain 619 (ThermoFisher) were used for distinguishing live from dead cells. To stain for the Nur77 620 transcription factor, the Nur77 monoclonal antibody (clone 12.14) was used in combination with 621 the Foxp3 Transcription Factor Staining Buffer Set (both from ThermoFisher) by the 622 27 manufacturer's protocol. Live/dead viability staining and surface staining were done for 20 623 minutes at 4°C, and intracellular staining was done for 30 minutes at room temperature. Samples 624 were then fixed with 1% paraformaldehyde/PBS for 1 hour before being analyzed by a 625
MACSQuant flow cytometer (Miltenyi Biotec). FlowJo Software (Tree Star, Portland, OR) was 626 used to analyze the collected data. Single lymphocytes were gated by forward scatter versus 627 height and side scatter for size and granularity, and dead cells were excluded. 628
Normalization and statistical analysis 629
To compare the cellular expression of Nur77 and CD69 expression levels between time 630 points, the MFI values were normalized as follows: experimental values were divided by the 631 difference between the isotype control MFI (minimum response) and the peptide control MFI 632 (maximum response). 633
Each figure represents a minimum of 2 similar experiments, with 2 to 4 biological replicates 634 in each experiment. Data are represented as mean ± standard error of the mean (SEM). For 635 comparing two groups, a two-tailed, unpaired student's t-test was used. For more than two 636 groups, the data were analyzed using a one-way ANOVA. A p value < 0.05 was considered to be 637 statistically significant. Analysis was performed using GraphPad Prism, Ver. 7 (GraphPad 638 Software, La Jolla, CA). Mononuclear lung cells were obtained from three individual C57BL/6 mice, 9 weeks after 729 low-dose aerosol infection with Mtb Erdman. Single TB10.44-11-tetramer + CD8 + T cells from each 730 mouse were sorted into 96-well plates and the CDR3α and CDR3β sequences determined as 731 described [19] . The analysis of a representative mouse is shown, for which 141 CDR3α 732 sequences was determined. A clonal expansion of TB10.44-11-tetramer + CD8 + T cells, as 733 previously described [19] , was suggested by the skewed distribution of TRAV and TRAJ families 734 (a), which shows an extreme bias in the use of TRAV7 and TRAJ15 gene segments, as well as a 735 dominant CDR3α amino acid (aa) length of 12 (b). (c) Analysis of all CDR3α aa sequence with a 736 length of 12 (n=112) identify a consensus motif of CAVSGGGRALIF for TB10.44-11-specific CD8 + 737 T cells. 738
Amplification of CDR3α and CDR3β sequences from the same well allowed pairing of 739 TCRα and TCRβ for individual TB10.44-11-specific CD8 + T cells. Three individual mice were 740 analyzed in this manner (d). We identified an expanded CDR3β sequence containing the 741 "xDRENSD" motif, the same motif that had been previously defined by NexGen sequencing [19] . 742 Thus, mouse L1 had an expansion of CD8 + T cells with the CASSLDRENDYTF CDR3β sequence, 743 mouse L2 was dominated by CD8 + T cells using the CDR3β sequence CASSQDRENDYTF, and 744 mouse L3 expressed two major expansions, one encoding CASSLDRENDYTF and the other, 745 33 CASSDDRENDYTF (d). Based on our ability to pair the CDR3α and CDR3β sequences, we 746 detected an interesting reciprocal conservation. Namely, the 'xDRENSD' CDR3β motif was 747 matched to a 'SxGGRA' CDR3α motif (e). Finally, we identified an expansion of a T cell clone in 748 mouse L1, which expressed a novel sequence that we had not previously observed (i.e., 749 CASSPDRGNTGQLYF) (d, e). Thus, with a high degree of confidence, we paired the CDR3α and 750
CDR3β sequences belonging to 5 distinct TB10.44-11-specific CD8 + T cell clones that had been 751 expanded in lungs of Mtb-infected C57BL/6 mice. The TCRα and TCRβ cDNAs were 752 reconstructed and cloned using standard methods, and retrogenic mice were subsequently 753 produced [19, 71, 72] . TCRα   TCRβ   TRBV12-2 TRBD1 TRBJ2-2 CASSRDRENSDYTF  CAVSQGGRALIF TRAV7-3  TRAJ15   TRBV12-2 TRBD1 TRBJ2-2 CASSLDRENSDYTF  CAVSGGGRALIF TRAV7D-3 TRAJ15   TRBV12-2 TRBD1 TRBJ2-2 CASSLDRENSDYTF  CAVSGGGRALIF TRAV7-3  TRAJ15   TRBV2  TRBD1 TRBJ2-2 CASSQDRENSDYTF  CAVSTGGRALIF TRAV7D-3 TRAJ15   TRBV2  TRBD1 TRBJ2-2 
